SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹6.31 Cr | ₹4.98 Cr | ₹4.42 Cr | ₹4.58 Cr | ₹7.16 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹6.31 Cr |
| Mar2024 | ₹4.98 Cr |
| Mar2023 | ₹4.42 Cr |
| Mar2022 | ₹4.58 Cr |
| Mar2017 | ₹7.16 Cr |
How is Deferred Tax Assets / Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹6.31 Cr | 26.80 | |
| Mar2024 | ₹4.98 Cr | 12.55 | |
| Mar2023 | ₹4.42 Cr | -3.34 | |
| Mar2022 | ₹4.58 Cr | -36.07 | |
| Mar2017 | ₹7.16 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,231.4 Cr | -3.3% | -6.1% | -30.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -3.3% |
-6.1% |
-30.1% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses